Masimo Corp. (NASDAQ:MASI) EVP Thomas Samuel Mcclenahan sold 10,000 shares of the business’s stock in a transaction dated Friday, September 30th. The stock was sold at an average price of $59.00, for a total transaction of $590,000.00. Following the completion of the transaction, the executive vice president now directly owns 10,000 shares of the company’s stock, valued at $590,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Masimo Corp. (NASDAQ:MASI) opened at 59.85 on Friday. The firm has a market cap of $2.95 billion, a PE ratio of 31.38 and a beta of 0.70. Masimo Corp. has a one year low of $33.03 and a one year high of $60.52. The company’s 50-day moving average is $59.06 and its 200-day moving average is $51.33.
Masimo Corp. (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.16. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. The company had revenue of $172.64 million for the quarter, compared to the consensus estimate of $166.02 million. During the same period last year, the company posted $0.36 EPS. The firm’s quarterly revenue was up 10.9% compared to the same quarter last year. On average, analysts forecast that Masimo Corp. will post $2.02 earnings per share for the current fiscal year.
Several large investors have recently bought and sold shares of the stock. Aperio Group LLC increased its stake in Masimo Corp. by 27.3% in the first quarter. Aperio Group LLC now owns 15,761 shares of the company’s stock worth $659,000 after buying an additional 3,379 shares during the last quarter. Virginia Retirement System bought a new stake in Masimo Corp. during the first quarter worth $1,452,000. Pacad Investment Ltd. bought a new stake in Masimo Corp. during the first quarter worth $519,000. Los Angeles Capital Management & Equity Research Inc. increased its stake in Masimo Corp. by 0.7% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 56,685 shares of the company’s stock worth $2,372,000 after buying an additional 400 shares during the last quarter. Finally, Ngam Advisors L.P. bought a new stake in Masimo Corp. during the first quarter worth $461,000. Institutional investors own 79.88% of the company’s stock.
A number of brokerages have weighed in on MASI. Zacks Investment Research downgraded shares of Masimo Corp. from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. BTIG Research reissued a “hold” rating on shares of Masimo Corp. in a research note on Friday, August 5th. Piper Jaffray Cos. reissued an “overweight” rating and set a $55.00 price target (up from $52.00) on shares of Masimo Corp. in a research note on Friday, August 5th. Finally, Wedbush reissued an “outperform” rating and set a $63.00 price target (up from $60.00) on shares of Masimo Corp. in a research note on Thursday, August 4th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $52.60.
About Masimo Corp.
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.